Evidence map›Paper›PMID 35977521›Full record

ArticleCell reports2022

The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways.

Milton Pereira, Danielle F Durso, Clare E Bryant, Evelyn A Kurt-Jones, Neal Silverman, Douglas T Golenbock, Ricardo T Gazzinelli

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
8.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 106 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Radiolysis Derivatives fromMolecules (Basel, Switzerland) · 2026
    Article
  11. Article
  12. Article
  13. Neuroimmune cross-talk inFrontiers in immunology · 2026
    Review
  14. Review
  15. TLR25 is endosomally located and responds toFrontiers in immunology · 2026
    Article
  16. Modulation of macrophage survival duringFrontiers in cellular and infection microbiology · 2026
    Review
  17. Article
  18. Review
  19. Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Milton PereiraDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA. Electronic address: milton.pereira@umassmed.edu.
Danielle F DursoDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Clare E BryantDepartment of Veterinary Medicine, University of Cambridge, Cambridge, UK.
Evelyn A Kurt-JonesDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Neal SilvermanDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Douglas T GolenbockDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
Ricardo T GazzinelliDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA; Centro de Tecnologia de Vacinas, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil; Fundação Oswaldo Cruz, Belo Horizonte, MG, Brazil; Plataforma de Medicina Translacional, Fundação Oswaldo Cruz, Ribeirão Preto, SP, Brazil. Electronic address: ricardo.gazzinelli@umassmed.edu.
University of Massachusetts Chan Medical School · USUniversidade Federal de Minas Gerais · BRUniversity of Cambridge · GB

Funding

Sugar-feeding behavior of the malaria vector Nyssorhynchus darlingi and development of effective attractive toxic sugar baits (ATSB) to increase intervention success in PeruU19AI089681 · NIAID · YALE UNIVERSITY · PI VINETZ, JOSEPH M. · 2010 to 2023
$20.1M
Innate Immune Activation in MalariaR01AI079293 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A., GOLENBOCK, DOUGLAS T · 2009 to 2024
$10.9M
From Drosophila Immunity to Anti-InflammatoriesR01AI060025 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Neal Silverman · 2004 to 2026
$9.4M
Group B. Streptococci and Toll-like ReceptorsR01AI052455 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GOLENBOCK, DOUGLAS T · 2002 to 2012
$4.2M
PHAGOCYTE RECEPTORS FOR LIPID AR01GM054060 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GOLENBOCK, DOUGLAS T. · 1997 to 2007
$3.4M
TLR Ectodomains for Microbial Detection and TherapeuticsU24AI082663 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2009 to 2013
$2.7M
Monocyte-derived dendritic cells in malariaR01NS098747 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GAZZINELLI, RICARDO TOSTES, LUSTER, ANDREW D · 2016 to 2020
$2.1M
Host Ciracadian Clock and MalariaR21AI150546 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GAZZINELLI, RICARDO TOSTES · 2020 to 2021
$461k
Activation of Insect Immunity by Gram-Negative BacteriaR56AI060025 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2011 to 2017
$459k
Biotechnology and Biological Sciences Research Council BB/V000276/1NIAID NIH HHS R01 AI052455NIAID NIH HHS R01 AI060025NIAID NIH HHS R01 AI079293NIAID NIH HHS R21 AI150546NIAID NIH HHS R56 AI060025NIAID NIH HHS U19 AI089681NIAID NIH HHS U24 AI082663NIGMS NIH HHS R01 GM054060NINDS NIH HHS R01 NS098747
6 · The paper itself

Abstract

Interleukin-1 receptor-associated kinases (IRAKs) -4, -2, and -1 are involved in transducing signals from Toll-like receptors (TLRs) via the adaptor myeloid differentiation primary-response protein 88 (MYD88). How MYD88/IRAK4/2/1 complexes are formed, their redundancies, and potential non-enzymatic roles are subjects of debate. Here, we examine the hierarchical requirements for IRAK proteins in the context of TLR4 activation and confirmed that the kinase activity of IRAK4 is essential for MYD88 signaling. Surprisingly, the IRAK4 scaffold is required for activation of the E3 ubiquitin ligase TNF receptor-associated factor 6 (TRAF6) by both MYD88 and TIR domain-containing adaptor protein inducing IFN-β (TRIF), a unique adaptation in the TLR4 response. IRAK4 scaffold is, therefore, essential in integrating MYD88 and TRIF in TLR4 signaling.

Indexed as

Interleukin-1 Receptor-Associated KinasesMyeloid Differentiation Factor 88Adaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportHumansSignal TransductionToll-Like Receptor 3Toll-Like Receptor 4Adaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportInterleukin-1 Receptor-Associated KinasesIRAK4 protein, humanMyeloid Differentiation Factor 88TLR4 protein, humanToll-Like Receptor 3Toll-Like Receptor 4cell signalingCP: ImmunologyGram-negativeinnate immunityIRAKLPSmacrophageNF-kBTLRToll-like receptorTRAF6

Identifiers

PMID35977521
PMCPMC9446533
OpenAlexW4292184449

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.